Changes in brain gene expression in schizophrenic and depressed patients

Area of Science:

• Neuroscience
• Molecular Biology
• Psychiatry

Background:

• Schizophrenia and unipolar depression are complex psychiatric disorders with unclear molecular underpinnings.
• Investigating post-mortem brain tissue offers insights into the molecular pathology of these conditions.

Purpose of the Study:

• To identify and characterize novel protein species with altered expression in the post-mortem brains of schizophrenic and depressive patients compared to controls.
• To explore the potential relationship between these protein expression changes and the disease state.

Main Methods:

• Poly(A+) mRNA was extracted from post-mortem brain samples of schizophrenics, unipolar depressives, and controls.
• In vitro translation of radiolabeled proteins was performed using a reticulocyte-lysate system.
• Protein species were analyzed using two-dimensional gel electrophoresis, quantified by image analysis, and normalized.

Main Results:

• Seven novel protein species with molecular weights ranging from 17 kDa to 38 kDa showed significant intensity changes in psychotic groups.
• One protein species (Mr = 26 kDa) was altered exclusively in schizophrenia, while three (Mr = 38, 34, 17 kDa) were altered exclusively in depression.
• Three protein species were common to both groups, with one decreasing in both and two showing opposing intensity changes between schizophrenia and depression.

Conclusions:

• The identified protein expression changes are likely reflective of specific mRNA abundance and target gene systems associated with schizophrenia and depression.
• These novel protein species represent potential biomarkers for psychiatric disorders.
• The observed changes were independent of post-mortem delay and mode of death, strengthening their relevance to the disease state.